Renu Vaish, V.P, Global Reg. Affairs at Edge Therapeutics, Inc. (EDGE), bought 350 shares at $11.00 ($4K) on 2015-10-06, disclosed to the SEC on 2015-10-08.
Open-market purchase of $4k EDGE by V.P, Global Reg. Affairs. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.